Stock Trading Canary

United States · SEC Form 4 · Snapshot date: 2026-10-19 · Built: 2026-10-19 · 中文

← United States · Coverage record

US · SEC FORM 4

ImmunityBio, Inc.

IBRX · Nasdaq · CIK 0001326110 · Healthcare · Biotechnology

INSIDER SIGNAL

No active buy signal

0 qualifying P purchase groups
in the current 180-day scoring window

17 Form 4 transaction lines observed in the same window
8 sales · 9 option, withholding, award, gift or other lines

Last qualifying purchase2023-06-05 · BLASZYK MICHAEL D · $198.0K

WHY NO ACTIVE SIGNAL?

Purchase activityNone
Recent buyingNone
Recent salesModerate
Buy signal statusInactive
Score anatomy

No score is calculated because there is no qualifying purchase in the active window. Unavailable inputs are not treated as zero or as a bearish signal.

ClusterNot calculated
Purchase sizeNot calculated
RoleNot calculated
RecencyNot calculated
ConvictionNot calculated

Why is there no score?

  • No qualifying open-market purchase supplies cluster, size, role, recency or conviction inputs.
  • Sales and other Form 4 activity remain visible as context and do not create a negative score.

Sales and other Form 4 activity are shown separately and do not create a negative buy signal. Absence of buying is not scored as bearish.

Purchase breadth, concentration & cluster buying

These modules activate when qualifying purchases enter the 180-day research window.

Insider activity timeline

Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.

AprMayJunJulAugSepOct
Selecky ChristobelDirector
○▼○▼○▼
Cohen CherylDirector
○▼○▼
Simon Barry J.Director
▼▼▼
● Purchase▼ Sale○ Other

—

SIGNAL HISTORY

No recorded active-signal snapshot

Scores are archived only when the company qualifies for a published US buy-signal snapshot. Last qualifying purchase: 2023-06-05 · BLASZYK MICHAEL D.

Recent Form 4 activity

0Purchases
16Sales
34Other Form 4 lines
22SEC filings · 365 days
BUYING0 qualifying P line(s) · 180 days
SELLING8 sale line(s) · context only
OTHER9 exercise / withholding / award / gift / other lines
10b5-1 / PLANNEDNot assessed

P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.

Market context

Market context has not been captured for this ticker yet. The daily market-context job processes the US universe in rotating batches.

Short interest

Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.

Shares short
124,092,202
Previous report
125,408,192
Avg daily volume
13,967,506
Days to cover
8.9

FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.

Historical equity purchases

Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.

Transaction dateReporting ownerTypeSecuritySharesAvg. priceApprox. valueSource
2023-06-05BLASZYK MICHAEL DPurchase (P)Common Stock71,915USD 2.75USD 198,023SEC filing ↗
2023-06-02Brennan John OwenPurchase (P)Common Stock25,000USD 2.83USD 70,700SEC filing ↗
2023-06-01Clark WesleyPurchase (P)Common Stock7,000USD 2.91USD 20,370SEC filing ↗
2021-10-08Adcock RichardPurchase (P)Common Stock1,930USD 8.81USD 17,005SEC filing ↗
2020-06-29Cambridge Equities, LP; MP 13 Ventures, LLC; SOON-SHIONG PATRICKPurchase (P)Common Stock3,710,000USD 12.12USD 44,965,200SEC filing ↗

Form 4 evidence

50 transaction lines in the latest 365-day window; 175 in local history.

DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-10-05Simon Barry J.Sale (S)Common Stock25,000USD 10.75USD 268,760SEC filing ↗
2026-10-02Cohen CherylSale (S)Common Stock81,056USD 10.50USD 851,088SEC filing ↗
2026-10-02Cohen CherylOption exercise / conversion (M)Common Stock55,979USD 2.98USD 166,817SEC filing ↗
Show recent Form 4 evidence (30 grouped rows)
DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-10-05Simon Barry J.Sale (S)Common Stock25,000USD 10.75USD 268,760SEC filing ↗
2026-10-02Cohen CherylSale (S)Common Stock81,056USD 10.50USD 851,088SEC filing ↗
2026-10-02Cohen CherylOption exercise / conversion (M)Common Stock55,979USD 2.98USD 166,817SEC filing ↗
2026-07-02Cohen CherylSale (S)Common Stock131,210USD 9.50USD 1,246,495SEC filing ↗
2026-07-02Cohen CherylOption exercise / conversion (M)Common Stock55,979USD 2.98USD 166,817SEC filing ↗
2026-07-01Selecky ChristobelSale (S)Common Stock159,478USD 9.02USD 1,438,492SEC filing ↗
2026-07-01Selecky ChristobelOption exercise / conversion (M)Common Stock159,478USD 2.99USD 476,489SEC filing ↗
2026-06-30Selecky ChristobelSale (S)Common Stock1,000USD 9.00USD 9,000SEC filing ↗
2026-06-30Selecky ChristobelOption exercise / conversion (M)Common Stock1,000USD 2.98USD 2,983SEC filing ↗
2026-06-29Selecky ChristobelSale (S)Common Stock95,722USD 9.01USD 862,455SEC filing ↗
2026-06-29Selecky ChristobelOption exercise / conversion (M)Common Stock95,722USD 2.94USD 281,387SEC filing ↗
2026-06-24Simon Barry J.Sale (S)Common Stock25,000USD 7.88USD 197,000SEC filing ↗
2026-06-04Simon Barry J.Sale (S)Common Stock23,033USD 7.18USD 165,377SEC filing ↗
2026-02-24Simon Barry J.Sale (S)Common Stock75,000USD 12.01USD 900,750SEC filing ↗
2026-02-23Simon Barry J.Sale (S)Common Stock165,000USD 10.25USD 1,691,250SEC filing ↗
2026-02-23Selecky ChristobelSale (S)Common Stock25,000USD 10.00USD 250,000SEC filing ↗
2026-02-23Selecky ChristobelOption exercise / conversion (M)Common Stock25,000USD 2.98USD 74,500SEC filing ↗
2026-02-22Simon Barry J.Option exercise / conversion (M)Common Stock15,243USD 0.00USD 0SEC filing ↗
2026-02-22Simon Barry J.Tax withholding (F)Common Stock6,026USD 8.70USD 52,426SEC filing ↗
2026-02-22Sachs David C.Option exercise / conversion (M)Common Stock40,650USD 0.00USD 0SEC filing ↗
2026-02-22Sachs David C.Tax withholding (F)Common Stock20,682USD 8.70USD 179,933SEC filing ↗
2026-02-22LAUER REGAN JOption exercise / conversion (M)Common Stock4,065USD 0.00USD 0SEC filing ↗
2026-02-22LAUER REGAN JTax withholding (F)Common Stock1,673USD 8.70USD 14,555SEC filing ↗
2026-02-22CALIFORNIA CAPITAL EQUITY, LLC; Cambridge Equities, LP; MP 13 Ventures, LLC; Nant Capital, LLC; SOON-SHIONG PATRICKOption exercise / conversion (M)Common Stock114,329USD 0.00USD 0SEC filing ↗
2026-02-22CALIFORNIA CAPITAL EQUITY, LLC; Cambridge Equities, LP; MP 13 Ventures, LLC; Nant Capital, LLC; SOON-SHIONG PATRICKTax withholding (F)Common Stock58,170USD 8.70USD 506,079SEC filing ↗
2026-02-22Adcock RichardOption exercise / conversion (M)Common Stock152,439USD 0.00USD 0SEC filing ↗
2026-02-22Adcock RichardTax withholding (F)Common Stock77,560USD 8.70USD 674,772SEC filing ↗
2026-02-20Simon Barry J.Sale (S)Common Stock10,000USD 9.25USD 92,500SEC filing ↗
2026-02-10Sachs David C.Option exercise / conversion (M)Common Stock82,236USD 0.00USD 0SEC filing ↗
2026-02-10Sachs David C.Tax withholding (F)Common Stock42,643USD 6.93USD 295,516SEC filing ↗

Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.

Snapshot & identity

Snapshot date2026-10-19
Ranking versionUS-v1.2
Data qualityPASS ELIGIBLE · —
TickerIBRX
CIK0001326110
SectorHealthcare
IndustryBiotechnology Yahoo Finance
SEC SIC2836 Biological Products, (No Diagnostic Substances)
ExchangeNasdaq

Data coverage

Local Form 4 history175 transaction lines from 2020-03-23 to 2026-10-05
10 P purchase lines · 52 S sale lines · 113 other lines
SEC company submissionsOpen SEC filings ↗

Local ledger as of 2026-10-19. Mapping status is an audit field and does not erase SEC filing evidence.